Evidence map›Paper›PMID 40864221›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2026

Shanshan Wang, Wei Liu, Xudong Ni, Dingwei Ye, Shaoli Song, Yao Zhu

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shanshan WangDepartment of Urology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.
Wei LiuDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Xudong NiDepartment of Urology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.
Dingwei YeDepartment of Urology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China.
Shaoli SongDepartment of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China.
Yao ZhuDepartment of Urology, Fudan University Shanghai Cancer Center, 270 Dong'an Road, Shanghai, 200032, China. zhuyao@fudan.edu.cn.ORCID http://orcid.org/0000-0001-7950-6669

Funding

Innovative Research Group Project of the National Natural Science Foundation of China 81972375Innovative Research Group Project of the National Natural Science Foundation of China 82172621Innovative Research Group Project of the National Natural Science Foundation of China 82473381Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning TP2022051Program of Shanghai Academic Research Leader 23XD1420600
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Metastatic castration-resistant prostate cancerPET/CT imagingTROP2-targeted therapy

Identifiers

PMID40864221

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.